PATENT CLAIM ANALYSIS

Application Number: 16155386
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["514", "077000"]

Abstract:
This invention relates to the large-scale production of psilocybin for use in medicine. More particularly, it relates to a method of obtaining high purity crystalline psilocybin, particularly, in the form of Polymorph A. It further relates to a method for the manufacture of psilocybin and intermediates in the production thereof and formulations containing psilocybin.

Claim (Index 1):
Crystalline psilocybin in the form Polymorph A or Polymorph A\u2032, characterised by one or more of:\n a. peaks in an XRPD diffractogram at 11.5, 12.0 and 14.5\u00b02\u03b8\u00b10.1\u00b02\u03b8; b. peaks in an XRPD diffractogram at 11.5, 12.0 and 14.5\u00b02\u03b8\u00b10.1\u00b02\u03b8, further characterised by at least one further peak at 19.7, 20.4, 22.2, 24.3 or 25.7\u00b02\u03b8\u00b10.1\u00b02\u03b8; c. an XRPD diffractogram as substantially illustrated in  FIG. 7 a  or  7 b ; or d. an endothermic event in a DSC thermogram having an onset temperature of between 205 and 220\u00b0 C. substantially as illustrated in  FIG. 8 a  or  8 b.

Metadata:
- Claim Count in Document: 43.0
- Percentile: 97.0
- Lexical Diversity: 1.71429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13922085', '13347423', '16124281', '14386424', '12665192']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.775400247464668
- 35 USC 102 Novelty (BERT): 0.517786040631756
- Combined Prediction Score: 0.7496388267813767
- Mean Citation Score: 284.004634
- Max Citation Score: 302.94016
- Similarity Product: 216.062150390625

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test